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Influence of Breed Size, Age, Fecal Quality, and Enteropathogen
Shedding on Fecal Calprotectin and Immunoglobulin A
Concentrations in Puppies During the Weaning Period
A. Grellet, R.M. Heilmann, B. Polack, A. Feugier, C. Boucraut-Baralon, D. Grandjean, N. Gr€utzner,
J. S. Suchodolski, J.M. Steiner, and S. Chastant-Maillard
Background: Fecal calprotectin and immunoglobulin A (IgA) are markers of intestinal inﬂammation and immunity in
adult dogs.
Hypothesis: Fecal calprotectin and IgA concentrations in puppies are not inﬂuenced by fecal moisture in puppies but by
enteropathogen shedding.
Animals: Three hundred and twenty-four puppies.
Methods: Fecal consistency was assessed by gross examination. Fecal moisture was evaluated before and after lyophiliza-
tion. Canine parvovirus and coronavirus were detected in feces by qPCR and qRT-PCR respectively. Giardia intestinalis anti-
gen was quantiﬁed by ELISA. The standard McMaster ﬂotation technique was used to detect eggs and oocysts in feces.
Fecal calprotectin and IgA concentrations were quantiﬁed by in-house radioimmunoassays.
Results: For each marker (IgA and calprotectin), a strong positive correlation was observed between concentration in
fresh feces and concentration in fecal dry matter. 75.6% of the puppies were found to be infected by at ≥1 of the entero-
pathogens evaluated. Fecal calprotectin concentration was signiﬁcantly inﬂuenced by age (P = .001), with higher concentra-
tions in younger puppies, but not by viral (P = .863) or parasitic infection (P = .791). Fecal IgA concentration was
signiﬁcantly inﬂuenced by enteropathogen shedding (P = .01), with a lower fecal IgA concentration in puppies shedding at ≥1
enteropathogen compared to puppies without any enteropathogen shedding, but not by age.
Conclusions: Fecal calprotectin and IgA are of no diagnostic value to detect presence of enteropathogens in clinically
healthy puppies or puppies with abnormal feces, but could help to better understand the maturation of digestive tract.
Key words: Age; Calprotectin; Digestive; Dog; Enteropathogens; Immunoglobulin A.
In dogs, gastrointestinal and hepatic diseases are thethird most frequent problem reported by owners in
United States and Australia.1 In the United Kingdom,
a survey based on client questionnaires reported that
up to 15% of dogs experienced mild diarrhea over a
2-week period.2 Another study observed that, among
sick animals presented for veterinary consultation, 7%
of visits were related to diarrhea.3 Diarrhea is even
more frequent in young dogs <6 months of age than in
adult dogs, with 25% of puppies having abnormal
feces during the weaning period.4,5 Diarrhea during
this period is a major problem as it can decrease daily
weight gain and increase the risk of death.6 As in other
species, diarrhea is multifactorial, involving factors
intrinsic to the dog (eg, breed size and age), nutritional
factors (eg, diet change without transition, food type
and quality), infectious diseases, and also lifestyle and
environmental stressors.5–11 Major enteropathogens
associated with diarrhea in weanling puppies are canine
parvovirus type 2 (CPV2),12 the Cystoisospora ohioen-
sis-complex, Cystoisospora canis,13 and Giardia duode-
nalis.14 Co-infections by these enteropathogens are
frequently reported in puppies.4,5 Several diagnostic
tests (such as PCR, antigen testing by ELISA, and
fecal examination) must be combined for accurate
diagnosis in cases of diarrhea in weanling puppies.
However, the use of such routine testing can be
diﬃcult and expensive.
In young children with gastroenteritis, several fecal
markers are used to assess shedding of enteropathogens
excreted, and to evaluate intestinal inﬂammation or
local immunity.15 Calprotectin and immunoglobulin A
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(IgA) are 2 of these markers. Calprotectin is a hetero-
dimeric protein complex mainly present in neutrophils,
monocytes, and reactive macrophages. In humans, fecal
calprotectin concentrations were reported to be
increased in patients with Crohn’s disease or ulcerative
colitis compared to healthy controls.16,17 Moreover,
they also correlated with disease severity as quantiﬁed
by endoscopy and histologic examination of biopsy
specimens.18 In adult dogs with chronic diarrhea, sig-
niﬁcantly higher serum and fecal calprotectin concen-
trations have been reported compared to healthy
dogs.19,20 Sensitivity and speciﬁcity of fecal calprotectin
for discriminating adult dogs with severe chronic diar-
rhea (Canine Chronic Enteropathy Clinical Activity
Index [CCECAI] ≥ 12) from dogs with mild to moder-
ate clinical signs (CCECAI < 12) were 53 and 92%,
respectively, when a cut-oﬀ value of 49 lg/g was
used.19 Secretory IgA is the predominant immunoglob-
ulin subtype present in secretions, protecting mucosal
surfaces from infectious agents. Therefore, fecal IgA
concentration may serve as a marker of mucosal
immunity.21 In dogs, fecal secretory IgA concentrations
previously have been used to evaluate intestinal
immunity.22,23
For interpretation of fecal IgA and calprotectin con-
centrations, how they are aﬀected by physiological fac-
tors such as breed size or age must be taken into
account. The canine species is characterized by large
interbreed variations, primarily by stature. The digestive
physiology of dogs is also known to diﬀer slightly
according to breed size. In large breed dogs, such as
German shepherds or Great Danes, fecal moisture con-
tent is higher, soft stools are more frequent and the
number of defecations is higher than in small breed
dogs.7,10,11,24 This diﬀerence may be a result of lower
mineral absorption, higher fermentative activity reﬂect-
ing higher intestinal permeability and a longer transit
time, or both.25–30 The same variation has been
described in puppies, with large breed puppies having
feces of lower consistency compared to small breed pup-
pies.6 Age also aﬀects concentrations of markers.
Indeed, lower fecal IgA concentrations were described
in puppies <6 months of age compared to adult
dogs.31,32 In humans, an eﬀect of age on fecal calpro-
tectin concentration has been described with higher con-
centrations being observed in healthy children compared
to healthy adults.33 The same variation has been
described between healthy puppies and healthy adults,
but these results were obtained from dogs housed in the
same breeding kennel.32 Therefore, the aims of our
study were to determine if calprotectin and IgA are
inﬂuenced by fecal moisture (Study 1) and to evaluate if
these fecal markers can be useful to detect infection by
an enteropathogen (virus, parasite, or both) in puppies,
taking into account the eﬀect of 2 potential biases, age
and breed size (Study 2).
Materials and Methods
The protocols of both studies were reviewed and approved by
Royal Canin Internal Ethics Committee.
Study 1: Relationship Among Fecal Moisture Content,
Fecal Quality and Fecal IgA and Calprotectin
Concentrations
A total of 70 purebred puppies from 18 litters from 10 diﬀer-
ent breeding kennels were included. Each puppy was identiﬁed
by a colored collar and its age and breed were recorded.
Depending on the mean adult body weight of their respective
breed, puppies were categorized into 2 groups (small breed if
the mean adult body weight was <25 kg; otherwise large breed).
For each puppy, fecal consistency was evaluated by a single
operator using a 13-point scale, based on the texture and shape
of the feces (from liquid to hard and dry).6 Fresh feces were
collected and weighed for each dog. If the stool volume defe-
cated was suﬃcient (≥15 g), stools were separated into 3 ali-
quots, 1 for fecal moisture evaluation and 2 for measurement of
fecal calprotectin and IgA concentrations. Water content of the
stools was determined by weighing feces before and after
lyophilization.30 Calprotectin and IgA were quantiﬁed by in-
house radioimmunoassays after extraction, as previously
described.22,32,34 All samples were analyzed using the same batch
of tracer and reagents. To correct for fecal moisture, results for
each marker were expressed as concentrations in fresh feces and
also normalized to dry matter.
Study 2: Relationship Between Fecal Markers and
Enteropathogen Shedding
A total of 254 purebred puppies from 64 litters from 33 diﬀer-
ent French breeding kennels were included. Puppies vaccinated
within the preceding 10 days before the visit and puppies with
clinical signs of weakness, dehydration, or anorexia were not
included in the study. However, puppies with an abnormal fecal
quality were included in the study. Each puppy was identiﬁed by a
colored collar and its age and breed were recorded. Depending on
the mean adult body weight of their respective breed, puppies were
categorized into small breed size or large breed size as described
above. For each puppy, fecal consistency was evaluated by a single
operator using a 13-point scale as previously described.6 Based on
growth rate deterioration, thresholds for abnormal feces in puppies
were previously validated and appeared to vary with breed stature
and age.6 Brieﬂy, feces with a score ≤5 were classiﬁed as abnormal
for large breed puppies regardless of age. For small breed puppies,
fecal scores ≤6 and ≤7 were classiﬁed as abnormal for 4–5 week
old puppies and for older puppies between 6 and 8 weeks old
respectively.
After collection, fecal samples were separated into 3 aliquots:
5 g of fresh feces were stored at +4°C for fecal examination and
the other 2 samples were frozen at 20°C for Giardia intestinalis
antigen quantiﬁcation and measurement of fecal calprotectin and
IgA concentrations respectively.
A rectal swab (medical dry swab, cotton tip diameter 2 mma )
was collected from each puppy immediately after stool collection
for detection of CPV2 and canine coronavirus (CCV). The swabs
were stored at 20°C until DNA extraction.
Fecal examination was performed by the standard McMaster
ﬂotation technique using a saturated magnesium sulfate solution
(density: 1.28 g/mL).35 All eggs and oocysts were identiﬁed accord-
ing to their morphological characteristics under light microscopy
by a single operator.36,37 Copro-antigens of G. intestinalis were
quantiﬁed by ELISAb in 100 mg of feces.38–40 An optical density
value >0.05 was considered positive according to the manufac-
turer’s instructions.
Feces were evaluated for the presence of DNA and RNA from
CPV2 and CCV by qPCR and qRT-PCR, respectively, as previ-
ously described.6 Results from duplicate PCR analyses from the
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extracted DNA (ie, 2 PCR assay were performed for each fecal
extract) were expressed semiquantitatively as virus loads. Puppies
were deﬁned as infected by CPV2 and CCV if viral loads were
>1010.3 and 109.3 copies respectively.6
After extraction, calprotectin and IgA were quantiﬁed by in-
house radioimmunoassays as previously described.22,32,34 All sam-
ples were analyzed using the same batch of tracer and reagents.
Data Management and Statistical Analysis
Data are shown as the median and range (min–max). Statistical
analyses were performed using a commercial software package.c
Spearman’s rho correlation coeﬃcient was used to evaluate the
correlation between fecal concentrations of each marker in fresh
feces and fecal dry matter.
Number of puppies with positive and negative fecal test results
for each enteropathogen was tabulated by age of the puppies. The
signiﬁcance of the univariate association between age and the
shedding of each enteropathogen was determined using
chi-squared-tests. A P value <.05 was considered statistically
signiﬁcant.
To assess the association between enteropathogens sheddings
and fecal IgA and calprotectin concentrations in puppies, 4 statis-
tical models were performed for each marker. In a ﬁrst step, uni-
variate analyses (Mann–Whitney and Kruskal–Wallis tests) were
performed to evaluate a possible association of each factor on
either fecal marker. Variables examined included age of puppies
(5–6/7–8/9–11 weeks of age), breed size (small/large), fecal quality
(normal/abnormal), G. inestinalis, C. ohioensis complex, C. canis,
Toxocara canis, CPV2, and CCV shedding (yes/no), shedding of
≥1virus (yes/no), shedding of ≥1parasite (yes/no), and shedding of
≥1 enteropathogen (yes/no). In a second step, relationships
between shedding of enteropathogens and fecal marker concentra-
tions were evaluated in 3 diﬀerent linear mixed models for each
marker. In a ﬁrst linear mixed model, eﬀects of each pathogen
(shedding of each pathogen [yes/no]) on either marker were evalu-
ated. In a second linear mixed model, inﬂuence of the type of
enteropathogens (shedding of ≥1 parasite [yes/no] and shedding
of ≥1 virus [yes/no]) on either fecal marker was evaluated. In a
last linear mixed model, global eﬀect of enteropathogens
(shedding of ≥1 enteropathogen [yes/no]) on both fecal markers
was evaluated. In all of these mixed models, breed size and age
of puppies were included as ﬁxed eﬀects and litter variable nested
within breeding kennel was deﬁned as a random term. For each
model, the normality of residuals distribution was assessed using
the Shapiro-Wilk test. According to residuals distribution for
each of the multivariable models, the outcome was log trans-
formed (fecal calprotectin concentration) or rank transformed
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Fig 1. Fecal quality in puppies included in both studies.
Fig 2. Correlation between fecal moisture and fecal score in 29
puppies. Scatter plot of the data overlaid with the regression line,
and 95% conﬁdence interval (gray zone). Each black point repre-
sents a dog (r = 0.59; P = .001).
Fig 3. Correlation between fecal calprotectin concentration in
fresh feces and fecal dry matter (n = 29). Scatter plot of the data
overlaid with the regression line, and 95% conﬁdence interval
(grey zone). Each black point represents a dog (r = 0.98;
P < .001).
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(fecal IgA concentration). Diﬀerences were considered signiﬁcant
for P values <.05. Quantitative data are presented as medians
with ranges.
Results
Study 1
Seventy puppies (64 classiﬁed as belonging to a large
breed) were included in the study (mean age, 8.8 weeks;
range 6–14 weeks). Among these, 29 (41%) puppies
defecated a suﬃcient volume of feces. These puppies
consisted of large breed puppies between 6 and
10 weeks of age (mean age, 8.5 weeks). A median fecal
score of 7 was obtained (range, 3–10; Fig 1) in the 29
puppies that defecated a suﬃcient volume of feces.
Fecal moisture ranged from 50 to 77.2% (median,
66.7%), with a strong negative correlation with fecal
scores (r, 0.59; P = .001; Fig 2).
Fecal calprotectin concentrations in fresh feces ran-
ged from 2.9 to 59.5 lg/g (median, 10.5 lg/g), and
from 5.8 to 200.8 lg/g (median, 32.2 lg/g) in fecal dry
matter. A strong positive correlation was observed
between fecal calprotectin concentration both in fresh
feces and in fecal dry matter (r, 0.98; P < .001; Fig 3).
A moderate negative correlation was observed between
fecal scores and fecal calprotectin concentrations in
fresh feces and in fecal dry matter (r, 0.38; P = .045;
and r, 0.49; P = .007 respectively).
Fecal IgA concentrations in fresh feces ranged from
0.3 to 24.2 mg/g (median, 3.6 mg/g) and from 0.9 to
62.3 mg/g (median, 11.8 mg/g) in fecal dry matter. A
strong positive correlation was observed between fecal
IgA concentrations in fresh feces and in fecal dry mat-
ter (r, 0.97; P < .001; Fig 4). A moderate negative cor-
relation was observed between fecal scores and fecal
IgA concentrations in either fresh feces or fecal dry
matter (r, 0.53; P = .003 and r, 0.64; P < .001
respectively).
Study 2
Among the 254 puppies included in the study, 180
(71%) were large breed puppies. Puppies were between
5 and 11 weeks of age (mean, 7.7 weeks). The mean
number of puppies included in each kennel was 8
(range, 1–18). A median fecal score of 8 was obtained
(range, 1–12; Fig 1).
Fig 4. Correlation between fecal IgA concentration in fresh feces
and fecal dry matter (n = 29). Scatter plot of the data overlaid
with the regression line, and 95% conﬁdence interval (grey zone).
Each black point represents a dog (r = 0.97; P < .001).
Table 1. Frequency of coshedding of enteropathogens in 254 puppies.
CPV2 CCV Toxocara canis Cystoisospora ohioensis Complex Cystoisospora canis Giardia Sp.
CPV2 3.9 (10) 3.5 (9) 7.1 (18) 6.7 (17) 9.4 (24)
CCV 2.8 (7) 5.5 (14) 0.4 (1) 16.5 (42)
T. canis 11.4 (29) 3.1 (8) 3.1 (8)
C. ohioensis complex 1.6 (4) 4.3 (11)
C. canis 8.7 (22)
Giardia sp.
Data are shown as % (number) of puppies.
Table 2. Prevalence of enteropathogens shedding based on age (n = 254).
Pathogens
Total Prevalence
(n = 254) % (ni)
Age of Puppies
Global P-Value
5–6 weeks
(n = 40) % (ni)
7–8 weeks
(n = 141) % (ni)
9–11 weeks
(n = 73) % (ni)
Coronavirus 22 (56) 10 (4)a 19.1 (27)a 34.2 (25)b .006
Parvovirus 18.9 (48) 22.5 (9) 19.9 (28) 15.1 (11) .571
Giardia 37.8 (96) 25 (10)a 29.8 (42)a 60.3 (44)b <.001
Toxocara canis 21.3 (54) 40 (16)a 21.3 (30)b 11 (8)b .001
Cystoisospora ohioensis complex 30.3 (77) 32.5 (13)a 36.9 (52)a 16.4 (12)b .008
Cystoisospora canis 10.6 (27) 25 (10)a 5 (7)b 13.7 (10)a <.001
ni = number of puppies infected for the category considered; n = total number of puppies in the category considered.
For each line, categories with diﬀerent letters (a, b) were signiﬁcantly diﬀerent (P < .05).
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In general, 2 diﬀerent enteric viruses and 4 parasites
were identiﬁed (Table 1). At least 1 enteropathogen was
identiﬁed in 75.6% (192/254) of the puppies. 71.7%
(182/254) of puppies were infected by ≥1 parasite and
37% (94/254) by ≥1 of the 2 viruses tested. One-third
(84/254) of the puppies were infected simultaneously
with ≥1 virus and 1 parasite (Table 2). Puppies between
5 and 8 weeks of age had a signiﬁcantly higher
prevalence of C. ohioensis complex and a lower preva-
lence of CCV and G. duodenalis than puppies between 9
and 11 weeks of age (Table 1).
Fecal calprotectin concentrations ranged from 2.9 to
421.4 lg/g feces (median, 15.2 lg/g feces). Of the 254
puppies included, 44 (17%) had a fecal concentration
>49 lg/g feces (threshold of clinical interest).19 Fecal
calprotectin concentration was signiﬁcantly aﬀected by
age (P = .001) but not by breed size (P = .217), viral
infection (CPV2, CCV, or both ; P = .863), or parasitic
infection (G. duodenalis, C. ohioensis complex, C. canis,
T. canis, or both; P = .791; Table 3). Fecal calprotectin
concentration was not associated with fecal score
(P = .851). The concentration of fecal calprotectin was
higher and more variable in younger puppies between 5
and 8 weeks of age than in the older puppies
(9–11 weeks of age; Fig 5). Twenty-two, 21, and 7% of
puppies had fecal calprotectin concentrations >49 lg/g
feces at, respectively, 5–6, 7–8, and 9–11 weeks of age.
Fecal IgA concentration ranged from 0.1 to 27.2 mg/g
feces (median, 4.5 mg/g feces). In contrast with calpro-
tectin, IgA concentration was signiﬁcantly inﬂuenced
Table 3. Evaluation of factors inﬂuencing fecal calprotectin concentrations in 254 puppies (univariate and multi-
variate analyses).
Variables
Fecal Calprotectin
Concentration
Median [range]
Initial Unadjusted
Analysis (P-Value)
Linear Mixed Model
Each Pathogen
Evaluated
Individually
(P-Value)
Shedding of at
Least One
Parasite
or One Virus
(P-Value)
Shedding
of at Least One
Pathogen (P-Value)
Age .001
5–6 weeks 17.8 [2.9–352.9] – – – –
7–8 weeks 18.8 [2.9–421.4] .202 .203 .177
9–11 weeks 5.5 [2.9–69.3] .004 .002 .002
Breed size
Small 19.8 [2.9–222.5] .096 .139 .218 .217
Large 11.9 [2.9–421.4]
Fecal score
Normal 14.6 [2.9–421.4] .851 – – –
Abnormal 18.1 [2.9–127.3]
Giardia
No shedding 19.6 [2.9–421.4] .007 .602 – –
Shedding 6.5 [2.9–222.5]
Cystoisospora ohioensis
No shedding 9.9 [2.9–352.9] .104 .056 – –
Shedding 2.5 [2.9–421.4]
Cystoisospora canis
No shedding 15 [2.9–421.4] .348 .73 – –
Shedding 15.3 [2.9–352.9]
Toxocara canis
Not shedding 11.9 [2.9–352.9] .005 .87 – –
Shedding 3.4 [2.9–421.4]
CPV2
No shedding 14.2 [2.9–421.4] .692 .65 – –
Shedding 18 [2.9–352.9]
CCV
No shedding 17 [2.9–421.4] .127 .67 – –
Shedding 6.5 [2.9–123.8]
Infection by at least one virus .502 – .863 –
No shedding 16.7 [2.9–421.4]
Shedding 1.9 [2.9–352.9]
Shedding of at least one parasite .788 – .791 –
No shedding 16.5 [2.9–93]
Shedding 13.9 [2.9–421.4]
Shedding of at least one enteropathogen .92 – .695
No shedding 16.5 [2.9–93]
Shedding 13.9 [2.9–421.4]
Bolded numbers are numbers with a P-value ≤.05.
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by enteropathogen shedding (P = .01) but by none of
the other factors tested (Table 4). Fecal IgA concentra-
tions were 1.4 times lower in puppies that were shed-
ding at least 1 enteropathogen (median, 4.1 mg/g feces;
range, 0.1–22.7 mg/g feces) than in puppies without
enteropathogen shedding (median, 5.7 mg/g feces; range,
0.5–27.2 mg/g feces; Fig 6). Fecal IgA concentration
was not found to be associated with fecal score
(P = .891).
Discussion
Diarrhea is common in puppies around the time of
weaning, and may be accompanied by slowed growth of
the puppies.6 Viral and parasitic infections are very
common in young puppies and are involved in weanling
diarrhea.5,6,14,41–43 The early detection of such infections
would avoid growth retardation and could decrease the
development of more severe forms of the disease. Thus,
noninvasive markers of digestive health, the concentra-
tions of which might be modiﬁed by the presence of
enteropathogens, would be of great utility in these
patients. Thus, our study investigated 2 fecal markers,
calprotectin and IgA, used in human pediatric gastroen-
terology for their utility in weanling puppies. In our
study, puppies that shed ≥1 enteropathogen had signiﬁ-
cantly lower fecal IgA concentrations than did puppies
without any enteropathogen shedding identiﬁed. This
lower fecal IgA concentration may be a cause or a con-
sequence of the enteropathogen shedding. Immunoglob-
ulin A can actively bind microrganisms, enterotoxins,
and other antigens, and prevent adherence and subse-
quent penetration of the intestinal wall. Thus, a lower
fecal IgA concentration could be caused by IgA being
utilized in antigen binding or by enterohepatic recircula-
tion of IgA. After IgA binds an antigen in the intestinal
lumen, it is either excreted in the feces or is actively
reabsorbed for destruction of the microorganism or
virus by hepatic Kuppfer cells. Reabsorption of IgA
could have been increased by an infection with an
enteropathogen, which could result in decreased fecal
concentrations of IgA. Conversely, the lower fecal IgA
concentration also could indicate the presence of altered
local immunity and thus serve as evidence for a higher
risk of infection with an enteropathogen. A positive
impact of fecal IgA on protection against infectious dis-
eases already has been described in other species. Mice
lacking secretory IgA exhibit a signiﬁcant delay in clear-
ance of rotavirus infection compared with mice that
have secretory IgA.44 In children, fecal IgA concentra-
tions also were shown to have an inﬂuence on protec-
tion against rotavirus infection and resulting disease.45
No signiﬁcant eﬀect of any viral (CCV or CPV2) or
parasite shedding (G. duodenalis, C. ohioensis complex,
C. canis, or T. canis) on fecal calprotectin concentra-
tion was observed. This lack of diﬀerence in calpro-
tectin concentrations between dogs that showed
enteropathogen shedding and those that did not could
be explained by the population of dogs enrolled in our
study (ie, healthy puppies or puppies presenting only
with an abnormal fecal quality without any other clini-
cal sign). In humans, the patient’s clinical status inﬂu-
ences the concentrations of this marker. In children
who are clinically healthy but infected by Giardia, no
eﬀect on fecal calprotectin concentration was
described.33 However, in human patients with viral gas-
troenteritis, fecal calprotectin concentrations were reported
to be associated with the severity of clinical signs.46 In
our study, 18.9% of puppies were found to be excreting
a high load of CPV2 but without any of the typical
clinical signs (eg, hemorrhagic diarrhea, vomiting, pros-
tration, dehydration, anorexia). This healthy carrier
state could explain the lack of association between
shedding of this virus and fecal calprotectin concentra-
tions. Another study comparing fecal calprotectin con-
centrations among healthy puppies, puppies with an
abnormal fecal quality, and puppies with clinical par-
vovirus infection would be needed to further elucidate
this relationship.
Fecal moisture in our study ranged from 50 to 77.2%
(median, 66.7%), with a negative correlation with fecal
scores, which is accordance with previous studies.10,30 A
negative correlation also was observed between fecal
markers and fecal score. The higher IgA and calpro-
tectin concentrations in puppies with liquid or soft feces
in this study do not seem to be a direct consequence of
stool consistency (dilution) because this negative corre-
lation was observed for fresh feces as well as for con-
centrations based on fecal dry matter. The negative
correlation between fecal score and fecal marker con-
centration could be explained by the eﬀect of age acting
as a confounding factor. Indeed age inﬂuence feces
quality (lower fecal score in very young puppies)6 and,
at the same time, age inﬂuences fecal concentrations of
both markers (higher fecal concentrations in very young
puppies).47
Our study indicates that fecal calprotectin concentra-
tions decrease and stabilize with age. This result is in
accordance with our longitudinal study performed in
young dogs around the age of weaning.47 In humans,
considerably higher fecal calprotectin concentrations
also have been observed in infants around the time of
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Fig 5. Box-and-whisker plots of fecal calprotectin concentrations
in 254 puppies. Each box represents the ﬁrst to the third quartiles
(25th to 75th percentiles), the bar in each box represents the med-
ian, and the whiskers represent the ﬁrst to ninth decile (10th to
90th percentiles). Values with diﬀerent letters (a,b) diﬀer signiﬁ-
cantly (P < .05).
Fecal calprotectin and IgA in puppies 1061
birth compared with those in healthy older children and
adults.33,48–50 In our study, 17% of puppies had high
fecal calprotectin concentrations (>49 lg/g) similar to
those observed in adult dogs with inﬂammatory bowel
disease, with large interindividual variations.19 These
high concentrations do not appear to be linked to viral
or parasite shedding because this eﬀect of age on fecal
calprotectin concentrations was still observed when
both variables (age and enteropathogen shedding) were
taken into consideration within the same statistical
model. Moreover, we previously observed a sponta-
neous normalization of fecal calprotectin concentrations
in healthy puppies during the weaning period.47 The
type of food (eg, natural milk, industrial milk, dry
food) may have inﬂuenced fecal calprotectin
concentrations. Human infants who are exclusively
breastfed show signiﬁcantly higher fecal calprotectin
concentrations compared to those receiving a mixed
diet.49,51 The eﬀect of natural milk may depend on sev-
eral factors such as hormones (eg, ghrelin, leptin),
cytokines and other immunostimulants and growth fac-
tors (eg, epidermal growth factor, granulocyte colony-
stimulating factor), which all contribute to the develop-
ment of the gastrointestinal immune system.51 Milk
ingestion was not controlled in our study, with puppies
having free access to maternal milk. However, from 5
to 8 weeks of age, the proportion of natural maternal
milk decreases continuously in a puppie’s diet because
of physiologic progressive weaning. Developmental pro-
cesses occurring in the digestive tract during this period
Table 4. Evaluation of factors inﬂuencing fecal IgA concentrations in 254 puppies (univariate and multivariate
analyses).
Variables
Fecal IgA
Concentration
Median [Range]
Initial Unadjusted
Analysis (P-Value)
Linear Mixed Model
Each Pathogen
Evaluated
Individually
(P-Value)
Shedding of at
Least One Parasite
or One Virus
(P-Value)
Shedding of at
Least One
Pathogen
(P-Value)
Age
5–6 weeks 2.3 [0.3–22.7] .003 – – –
7–8 weeks 5.5 [0.1–24.2] .971 .506 .489
9–11 weeks 4.1 [0.2–27.2] .375 .193 .176
Breed size
Small 5.7 [0.14–19.2] .019 .091 .138 .197
Large 3.9 [0.1–27.2]
Fecal score
Normal 4.4 [0.1–27.2] .891 – – –
Abnormal 5.4 [0.3–21.9]
Giardia
No shedding 4.9 [0.1–27.2] .816 .127 – –
Shedding 4.3 [0.1–22.7]
Cystoisospora ohioensis
No shedding 4.5 [0.1–27.2] .126 .333 – –
Shedding 4.5 [0.1–20.8]
Cystoisospora canis
No shedding 4.4 [0.1–27.2] .048 .021 – –
Shedding 5.5 [0.2–22.7]
Toxocara canis
No shedding 4.8 [0.1–27.2] .165 .415 – –
Shedding 4 [0.1–20.8]
CPV2
No shedding 4.5 [0.1–27.2] .535 .373 – –
Shedding 3.8 [0.3–21.9]
CCV
No shedding 4.8 [0.1–27.2] .118 .802 – –
Shedding 3.3 [0.1–20.8]
Infection by at least one virus .743 – .864 –
No shedding 4.8 [0.1–27.2]
Shedding 3.7 [0.1–21.9]
Infection by at least one parasite .062 – .058 –
No shedding 5.5 [0.5–27.2]
Shedding 4.2 [0.1–22.7]
Infection by at least one enteropathogen .072 – – .01
No shedding 5.7 [0.5–27.2]
Shedding 4.1 [0.1–22.7]
Bolded numbers are numbers with a P-value ≤.05
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of life also could explain the higher fecal calprotectin
concentrations. During the ﬁrst weeks of life, intestinal
permeability is higher52, which may lead to transepithe-
lial migration of neutrophils, as observed in adults with
inﬂammatory bowel disease.53 The physiological estab-
lishment and stabilization of the gut microbiota also
may have an eﬀect on calprotectin release as has been
suggested in humans.54,55 The higher calprotectin con-
centrations observed also could be linked to bacterial
gastrointestinal infections as described in children.15,56
Conclusion
Our study indicates that fecal calprotectin and IgA
are of no diagnostic value to detect the presence of an
enteropathogen in clinically healthy puppies or puppies
with abnormal feces. However, these markers might be
useful to better understand the maturation of the
digestive tract, the development of systemic and local
immunity, and the establishment and stabilization of
the gut microbiota. The development of noninvasive
fecal biomarkers that may prove to be useful to evalu-
ate gastrointestinal health in puppies remains a
challenge.
Footnotes
a Copan, Brescia, Italy
b ProSpecT-Giardia Microplate Assay kit, Remel, France
c SAS, version 9.3, SAS Institute Inc., Cary, NC
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